Tyrian Diagnostics Completes Feasibility Study for Tuberculosis Diagnostic

Tyrian Diagnostics Limited announced that the Company has completed Milestone 4 of a feasibility study in collaboration with Becton, Dickinson and Company (BD) to determine the suitability of Tyrian’s proprietary tuberculosis (TB) protein markers for the development of rapid diagnostic tests to detect active TB disease.
The Earth Times